Protalix BioTherapeutics, Inc.

TASE:PLX Stock Report

Market Cap: ₪407.5m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Protalix BioTherapeutics, Inc. Company Information

Protalix BioTherapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Protalix BioTherapeutics, Inc.
  • Ticker: PLX
  • Exchange: TASE
  • Founded: 1993
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$112.467m
  • Listing Market Cap: US$407.534m
  • Shares Outstanding: 57.38m
  • Website:

Number of Employees


  • Protalix BioTherapeutics, Inc.
  • 2 University Plaza
  • Suite 100
  • Hackensack
  • New Jersey
  • 7601
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PBDADB (Deutsche Boerse AG)YesOrdinary SharesDEEURJan 2007
PLXTASE (The Tel-Aviv Stock Exchange)YesOrdinary SharesILILSJan 2007

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/03/23 00:00
End of Day Share Price 2023/03/20 00:00
Annual Earnings2022/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.